Dan Lemaitre, Director at ENDOLOGIX INC /DE/ (ELGX), bought 45,044 shares at $4.43 ($200K) on 2017-05-22, disclosed to the SEC on 2017-05-23.
Seasonal purchase ($200k) by Director — this insider has traded ELGX in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.43 | 22,522 | $100K | 50.0% |
| 2 | $4.43 | 22,522 | $100K | 50.0% |
| Total | $4.43 avg | 45,044 | $200K | 100% |
| Filing → |
| GMED | SELL | 2023-05-17 | $2.5M | — | Filing → |
| GMED | SELL | 2021-03-11 | $1.9M | — | Filing → |
| ELGX | SELL | 2020-09-17 | $3K | — | Filing → |